SPC187
Idelalisib eða lyfjafræðilega nothæft salt þar af
Status:
VeittApplication date:
13.3.2017Application published:
15.4.2017Grant published:
15.3.2018
Max expiry date:
18.9.2029Next due date:
31.5.2026Medicine name:
ZydeligMedicine for children:
No
Timeline
Today
13.3.2017Application
15.4.2017Publication
15.3.2018Registration
11.5.2026Expires
Marketing license
IS authorization number:
EU/1/14/938/001; EU/1/14/938/002Date:
10.10.2014
Foreign authorization number:
EU/1/14/938Date:
10.9.2014
Owner
Name:
ICOS CORPORATIONAddress:
Lilly Corporate Center, Indianapolis US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1761540
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 5.5.2025
Expires: 11.5.2026
Payer: Árnason Faktor ehf.